LIVINGSTON,
NJ
Milestone Scientific Inc, a
medical R&D company that designs, patents, incubates and commercializes a
growing portfolio of innovative injection technologies, announced the
appointment of Joseph M. Chalil, MD, MBA, FACHE to the company's Global
Advisory Board, where he will aid in the commercial development and worldwide
rollout of the company's medical instruments.
Dr. Chalil is a physician and executive at Boehringer
Ingelheim, the world's largest privately held pharmaceutical company. Dr.
Chalil is also the Chairman of Global Clinical Research and Trial Network of
the American Association of Physicians of Indian Origin (AAPI), the second
largest physician organization in the US, second only to the AMA, and has
served as scientific advisor to AAPI for the past five years.
Dr. Chalil holds three US patents and his research
includes clinical trial management in cystic fibrosis, multiple myeloma, and
publications in the American Journal of Respiratory and Critical Care Medicine.
He is a visiting professor at various universities and board member of various
companies. Dr. Chalil is an expert in US healthcare policy and a strong
advocate for patient centered care. Recent honors include; Recipient of the
prestigious 2015 AAPI National Presidential Award; Recipient of the 2013
Outstanding 50 Asian Americans in Business Award; 2013 AAPI New York
President's Award winner; Honoree by the American Association of Cardiologists
of Indian Origin (AACIO) for his achievements in the field of cardiology in
2013; and Boehringer Ingelheim President's Club winner for 2011 & 2014.
Leonard Osser, CEO of Milestone Scientific, commented,
"We welcome the involvement of Dr. Chalil as we enter the final stages of
our U.S.
clinical trials for the epidural instrument. Dr. Chalil brings an impressive
background and a wealth of commercial and regulatory experience as a senior
executive at the world's largest privately held pharmaceutical company. As a
successful inventor and physician, he also brings a unique perspective from
both an entrepreneurial and clinical perspective. We look forward to working
closely with Dr. Chalil as we advance toward finalization of our 400 patient
epidural study and then begin the full commercial rollout of our epidural
instrument following regulatory marketing clearance."
Milestone Scientific Inc. (MLSS) is a medical R&D
company that designs, patents, incubates and commercializes a growing portfolio
of innovative injection technologies. Milestone's computer-controlled systems
make injections precise, efficient, and virtually painless.
For more information please visit: www.milestonescientific.com.
